The main themes of this meeting are: 1) Explore how small GTPases regulate cellular membrane processes, such as secretion and endosomal trafficking; 2) Determine how these pathways contribute to cell function, how alterations in these trafficking pathways cause human disease, and explore their potential as druggable targets; 3) Examine how emerging technologies – including state-of-the-art super resolution and intravital microscopy, CRISPR-based gene editing, induced pluripotent stem cells, and organoids – are advancing our understanding of small GTPase in normal and pathophysiological states.

Conference sessions will present the latest research findings, and foster extensive and engaging discussion on:
  • Biophysical and biochemical characteristics of small GTPases
  • Regulation of the secretory pathway
  • Trafficking in the endosomal system
  • Regulation of cellular processes, including cell growth and migration
  • How alterations in these pathways contribute to cancer and neurodegenerative diseases (ALS and Parkinson's disease)
  • Cutting-edge technologies for cell biology research

The program includes an opening keynote lecture from Jennifer Lippincott-Schwarz, PhD (Howard Hughes Medical Institute, Janelia Research Campus) and a closing keynote EMBO Lecture from Marino Zerial, PhD (Max Planck Institute of Molecular Cell Biology and Genetics). The conference features nine oral sessions, each with invited talks from submitted abstracts; two poster sessions, including a session with two-minute oral overviews of each poster; “Meet the Experts” sessions; and workshops on career development, microscopy, and essential reagents, including CRISPR and antibodies.

Platinum Supporters